2020
DOI: 10.3892/or.2020.7621
|View full text |Cite
|
Sign up to set email alerts
|

Supervillin promotes tumor angiogenesis in liver cancer

Abstract: Tumor angiogenesis is a hallmark of liver cancer and is necessary for tumor growth and progression. Supervillin (SVIL) is highly expressed and implicated in several malignant processes of liver cancer. However, the functional relationships between SVIL and tumor angiogenesis in liver cancer have not yet been fully elucidated. The present study was based on bioinformatics analysis, patient tissue sample detection, three-dimensional simulated blood vessel formation, a series of cytological experiments and mouse … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 49 publications
0
6
0
Order By: Relevance
“…5k ). JCAD has been previously implicated in endothelial dysfunction, pathological angiogenesis, and atherosclerotic plaque formation ( 65 ), whereas the role of SVIL in cardiovascular disease remains unknown, but it may promote angiogenesis and epithelial to mesenchymal transition ( 66 ).…”
Section: Resultsmentioning
confidence: 99%
“…5k ). JCAD has been previously implicated in endothelial dysfunction, pathological angiogenesis, and atherosclerotic plaque formation ( 65 ), whereas the role of SVIL in cardiovascular disease remains unknown, but it may promote angiogenesis and epithelial to mesenchymal transition ( 66 ).…”
Section: Resultsmentioning
confidence: 99%
“…For example, SVIL can promote cancer cell survival by regulating the level of p53 11 , or in response to signals of intratumoral hypoxia, thereby increasing its own expression, ultimately leading to tumor metastasis and poor survival in liver cancer 10 . In addition, SVIL can promote tumor development in hepatocellular carcinoma by promoting angiogenesis, which can be inhibited by targeting SVIL, and is considered as a potential therapeutic biomarker 12 . However, the expression of SVIL in bladder cancer and its functional relationship with tumors has not yet been reported.…”
Section: Introductionmentioning
confidence: 99%
“…JCAD has been previously implicated in endothelial dysfunction, pathological angiogenesis, and atherosclerotic plaque formation, 65 whereas the role of SVIL in cardiovascular disease remains unknown, but it may promote angiogenesis and epithelial to mesenchymal transition. 66
Figure 7 Dissection of JCAD/SVIL locus (A and B) Gene expression module for SVIL in SMCs (A) and pericardial fluid cells (B). GWAS-linked genes in red.
…”
Section: Resultsmentioning
confidence: 99%